ºÐÀÚÀ¯ÀüÇнÇÇè½Ç (´Ü±¹´ëÇб³ ºÐÀÚ»ý¹°Çаú)
81
Group I Intron-Based Therapeutics Through Trans-Splicing Reaction. Progress in Molecular Biology and Translational Science 2018; 159: 79-100
À̼º¿í
2018/10/16
128
80
TS ribozyme review-WIREs RNA-Cover Image 2018 Vol.9 No.3
À̼º¿í
2018/04/24
129
79
Therapeutic applications of group I intron-based trans-splicing ribozymes. WIREs RNA. 2018; 9: e1466.
À̼º¿í
2018/04/24
110
78
Development of RNA aptamer that inhibits methyltransferase activity of dengue virus. Biotechnology Letters 2018; 40: 315-324
À̼º¿í
2018/02/15
431
77
Effects of human mesenchymal stem cells co-culture on calcium-induced differentiation of normal human keratinocytes. Stem Cells 2017; 35: 1592-1602
À̼º¿í
2017/06/02
271
76
Lee, J. H.,, and Lee, S.-W. (2017) The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches. Gastroenterology Research and Practice 2017, 7521987; doi: 10.1155/2017/752
À̼º¿í
2017/05/17
190
75
Lee, C. H., Kim, J. H., and Lee, S.-W. (2017) The role of microRNA in pathogenesis and as markers of HCV chronic infection. Current Drug Targets 18(7): 756-765
À̼º¿í
2017/05/17
157
74
Specific and efficient regression of cancers harboring KRAS mutation by targeted RNA replacement. Molecular Therapy 2017; 25(2): 356-367.
À̼º¿í
2017/02/02
350
73
Inhibition of Japanese encephalitis virus (JEV) replication by specific RNA aptamer against JEV methyltransferase. Biochemical and Biophysical Research Communications 2017; 483: 687-693.
À̼º¿í
2017/01/20
1592
72
Genotyping of 19 red cell antigens, including RHD, using liquid bead arrays. Clinica Chimica Acta 2016; 462: 111-117
À̼º¿í
2016/12/28
225
71
Hepatitis C virus infection stimulates transforming growth factor-1 expression through up-regulating miR-192. Journal of Microbiology 2016; 54(7): 520-526.
À̼º¿í
2016/06/24
364
70
Therapeutic applications of aptamer-based riboswitches. Nucleic Acid Therapeutics 2016: 26(1); 44-51
À̼º¿í
2016/02/19
246
69
Image-guided suicide gene therapy utilizing multifunctional hTERT-targeting adenovirus for clinical translation in hepatocellular carcinoma. Theranostics 2016; 6(3): 357-368. doi: 10.7150/thno.13621
À̼º¿í
2016/02/19
350
68
Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein. Molecular Therapy-Nucleic Acids (2015) 4, e254; doi:10.1038/mtna.2015.30
À̼º¿í
2015/10/07
277
67
Targeting the MicroRNA Passenger Strand for Regulating Therapeutic Transgenes. Nucleic Acid Therapeutics (2015) 25(4): 209-218
À̼º¿í
2015/07/22
326
66
Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation. Scientific Reports (2015) 5, 12315; doi: 10.1038/srep12315.
À̼º¿í
2015/07/20
412
65
Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon
À̼º¿í
2015/03/11
336
64
Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancr Letters 356 (2015) 918-928.
À̼º¿í
2014/12/04
801
63
Conditional and Target-Specific Transgene Induction through RNA Replacement Using an Allosteric Trans-Splicing Ribozyme. ACS Chemical Biology 9(11): 2491-2495.
À̼º¿í
2014/11/21
554
62
Selective expression of transgene using hypoxia-inducibletrans-splicing group I intron ribozyme
À̼º¿í
2014/11/08
468
1
[2]
[3]
[4]
[5]
Copyright 1999-2021
Zeroboard
/ skin by
ROBIN